Inventor · disambiguated record
Pierre Bougneres
Also filed as: BOUGNERES PIERRE
3 granted patents·13 pending applications·42 citations·filing 2001–2024
71Inventor score
Files withINST NAT SANTE RECH MED8ADRENAS THERAPEUTICS INC3APHP ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS1
Top patents by PatentIndex Score
16 records- 0193US9066966B2Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxiaINST NAT SANTE RECH MED·Filed 2013·Granted Jun 30, 2015·29 cites·21 claims
- 0292US10337027B2Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxiaINST NAT SANTE RECH MED·Filed 2015·Granted Jul 2, 2019·13 cites·6 claims
- 0388US2025109408A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0487US2025109407A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0575US2022090128A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0675US2021340565A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0772US2020157564A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0871US2025304925A1Adeno-associated virus gene therapy for 21-hydroxylase deficiencyADRENAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0964US2018334687A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1061US2016024526A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureAPHP ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS·Filed 2014·Application pending·0 cites
- 1158US12195767B2Adeno-associated virus gene therapy for 21-hydroxylase deficiencyADRENAS THERAPEUTICS INC·Filed 2019·Granted Jan 14, 2025·0 cites·20 claims
- 1244US2024191213A1Gene therapies for 21-hydroxylase deficiencyADRENAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1344US2005112570A1Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin geneFiled 2002·Application pending·0 cites
- 1442US2004076975A1Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fatFiled 2001·Application pending·0 cites
- 1541US2005118622A1Methods for predicting development of insulin resistanceFiled 2004·Application pending·0 cites
- 1638US2004180358A1Methods for predicting therapeutic response to agents acting on the growth hormone receptorFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pierre Bougneres files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →